Skip to content

WHWK WHWK Investment Proceeds

Investment Proceeds at other companies

IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$162.53M-12.8%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$50M-1.0%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$25.51M
Immunome logo
ImmunomeIMNM
$0-100%

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
Net income-$22.2M-130%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total debt$833.0K-34.3%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$226.49M+131%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Return on equity-68.5%-86.2pp
Debt / equity0.0×
Current ratio11.4×-7.6×

Where this comes from

Reported directly by WHWK in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments.

The official record: WHWK’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WHWK's investment proceeds?
WHWK (WHWK) reported investment proceeds of $38.62M in Q1 2026.
How has WHWK's investment proceeds changed year-over-year?
WHWK's investment proceeds increased by 162.8% year-over-year, from $14.69M to $38.62M.
What does investment proceeds mean?
Cash received from sales, maturities, and redemptions of investment securities across all categories.